Indian authorities seize J&J Baby Powder in response to Reuters report

pharmafile | December 19, 2018 | News story | Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation 

Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after Reuter’s revealed that the American firm had known its products contained cancer-causing asbestos since the 1970s.

India’s Central Drugs Standard Control Organization (CDSCO) took samples from samples from the firms Baddi plant in the state of Himachal Pradesh late on Tuesday.

Regional drug officer for the southern state of Telangana, Surendranath Sai said on Wednesday that he had also instructed officers to seize samples.

“On the basis of the news report, we are alerting staff to pick up samples. We will test them in a drug control lab here,” Said said to reuters. “We will take action accordingly. Certainly we are worried because millions of babies may be affected.”

The action comes after a Reuters’ investigation revealed that J&J had covered up reports that their Baby Powder contained asbestos since 1971.

In response J&J said that “Reuters article is one-sided, false and inflammatory,” as the company declared that “Johnson & Johnson’s baby powder is safe and asbestos-free.”

Louis Goss

Related Content

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence …


Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US …


GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test

US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective …

Latest content